Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinomaRyota Kurimoto(Chiba University), Yuichi Takiguchi(Chiba University)Oncology LettersMay 17, 201710.3892/ol.2017.6188Cited by 39SaveCiteExport RISWatch citationsRelated PapersDrug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation|International Journal of Oncology|2016|70Contrasting functions of the epithelial‑stromal interaction 1 gene, in human oral and lung squamous cell cancers|Oncology Reports|2021|12